Skip to content

Clinical trials

Completed Phase 4 Generalized Anxiety Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Generalized Anxiety Disorder Phase: Phase 4 Status: Completed Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20043
20058
20063
20071
20082
20093
20103
20122
20131
20141
20152
20181
20192

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital4
University of Pennsylvania3
University of South Florida2
AbbVie1
Creighton University1
Eli Lilly and Company1
Georgetown University1
H. Lundbeck A/S1
Marubeni Pharmaceuticals (Suzhou) Co., Ltd.1
McMaster University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Generalized Anxiety Disorder34
Anxiety Disorders24
Panic Disorder11
Phobia, Social5
Bipolar Disorder3
Major Depressive Disorder3
Agoraphobia2
Alcoholism2
Stress Disorders, Post-Traumatic2
Attention Deficit Disorder with Hyperactivity1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.